NCT01298479

Brief Summary

The purpose of this study is to determine the volumetric delivery of the Uniject.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 16, 2010

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 17, 2011

Completed
Last Updated

December 7, 2018

Status Verified

December 1, 2018

Enrollment Period

1 month

First QC Date

December 16, 2010

Last Update Submit

December 5, 2018

Conditions

Volume Delivery

Keywords

volume delivery

Outcome Measures

Primary Outcomes (1)

  • Weight of drug suspension delivered (estimated by change in mass of the Uniject(TM) delivery system).

    Visit 1

Study Arms (1)

Group 1

All subjects

Other: Uniject

Interventions

UnijectOTHER

single use container

Group 1

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

nurses

You may qualify if:

  • Nurses

You may not qualify if:

  • Non-nurses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pfizer Investigational Site

Brussels, B-1070, Belgium

Location

Related Links

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2010

First Posted

February 17, 2011

Study Start

May 1, 2010

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

December 7, 2018

Record last verified: 2018-12

Locations

BE(1)